Third View Private Wealth LLC Takes $3.46 Million Position in Haleon PLC Sponsored ADR $HLN

Key Points

• Third View Private Wealth LLC acquired a new stake of 342,380 shares in Haleon PLC Sponsored ADR (NYSE:HLN) in Q4, valued at approximately $3.461 million.
• Wall Street analysts hold a consensus rating of Moderate Buy for HLN with an average price target of $12.33, based on mixed ratings (2 Strong Buy, 4 Buy, 2 Hold, 1 Sell).
• Haleon disclosed a dividend of $0.1307 to be paid May 14 to holders of record April 10 (ex-dividend April 10); the article lists a payout ratio of 64.1% and states a yield of 266.0%.

Third View Private Wealth LLC acquired a new stake in Haleon PLC Sponsored ADR (NYSE:HLN - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 342,380 shares of the company's stock, valued at approximately $3,461,000.

Several other institutional investors have also modified their holdings of HLN. Brighton Jones LLC bought a new stake in shares of Haleon in the 4th quarter valued at approximately $187,000. AQR Capital Management LLC lifted its stake in shares of Haleon by 22.5% in the 1st quarter. AQR Capital Management LLC now owns 96,323 shares of the company's stock valued at $991,000 after purchasing an additional 17,720 shares during the last quarter. Focus Partners Wealth lifted its stake in shares of Haleon by 7.6% in the 1st quarter. Focus Partners Wealth now owns 73,106 shares of the company's stock valued at $752,000 after purchasing an additional 5,178 shares during the last quarter. Geneos Wealth Management Inc. lifted its stake in shares of Haleon by 33.0% in the 1st quarter. Geneos Wealth Management Inc. now owns 4,846 shares of the company's stock valued at $50,000 after purchasing an additional 1,203 shares during the last quarter. Finally, CW Advisors LLC lifted its stake in shares of Haleon by 11.6% in the 2nd quarter. CW Advisors LLC now owns 25,075 shares of the company's stock valued at $260,000 after purchasing an additional 2,601 shares during the last quarter. 6.67% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on HLN shares. Jefferies Financial Group reiterated a "buy" rating on shares of Haleon in a report on Tuesday, January 20th. Deutsche Bank Aktiengesellschaft downgraded Haleon from a "hold" rating to a "sell" rating in a report on Monday, January 12th. Wall Street Zen upgraded Haleon from a "hold" rating to a "buy" rating in a report on Saturday, March 21st. Weiss Ratings reiterated a "hold (c)" rating on shares of Haleon in a report on Thursday, January 22nd. Finally, Argus upgraded Haleon to a "strong-buy" rating in a report on Tuesday, March 17th. Two research analysts have rated the stock with a Strong Buy rating, four have assigned a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $12.33.

Haleon Stock Down 0.2%

NYSE:HLN opened at $9.83 on Tuesday. Haleon PLC Sponsored ADR has a 1-year low of $8.71 and a 1-year high of $11.42. The company has a 50-day moving average of $10.44 and a 200 day moving average of $9.93. The firm has a market cap of $43.81 billion, a PE ratio of 25.19 and a beta of 0.26. The company has a debt-to-equity ratio of 0.47, a current ratio of 0.92 and a quick ratio of 0.71.

Haleon (NYSE:HLN - Get Free Report) last released its quarterly earnings data on Saturday, February 14th. The company reported $6.32 earnings per share for the quarter. The business had revenue of $3.65 billion during the quarter. As a group, research analysts anticipate that Haleon PLC Sponsored ADR will post 0.43 EPS for the current fiscal year.

Haleon Dividend Announcement

The firm also recently disclosed a dividend, which will be paid on Thursday, May 14th. Investors of record on Friday, April 10th will be paid a $0.1307 dividend. The ex-dividend date of this dividend is Friday, April 10th. This represents a yield of 266.0%. Haleon's dividend payout ratio is 64.10%.

Haleon Company Profile

Haleon plc NYSE: HLN is a global consumer healthcare company formed through the separation of a large pharmaceutical group's consumer health business in 2022. Headquartered in the United Kingdom, Haleon develops, manufactures and markets a broad portfolio of over‑the‑counter medicines, oral health products, vitamins, minerals and supplements, and other consumer health goods designed for daily self‑care and symptom relief.

The company’s product mix spans categories such as oral care (toothpastes and sensitivity treatments), pain relief and analgesics, respiratory remedies, digestive health products, topical treatments and nutritional supplements.

Want to see what other hedge funds are holding HLN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Haleon PLC Sponsored ADR (NYSE:HLN - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.